Loading...
NYSE: A
Agilent Technologies, Inc.
Healthcare · Medical - Diagnostics & Research
●S&P 500 since 2000
Market Cap
$31.55B
52w High
$160.27
52w Low
$96.43
P/E
24.47
Volume
493.38K
Outstanding Shares
282.84M
Company profile
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
CEOPadraig McDonnell
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees17,900
IPO dateNov 18, 1999
Valuation
Forward P/E—
EV/EBITDA23.43
Enterprise value$42.98B
Stock splits
Nov 3, 2014699:500
Profitability & growth
Revenue growth6.96%
Gross margin52.23%▼3.44%vs FY2024
Operating margin20.61%▼6.87%vs FY2024
ROE19.33%▼11.56%vs FY2024
Analyst consensus
RatingBuy
Target price$165.00▲47.94%
29
Buy
8
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 27, 2026
View
EPS
Actual vs estimate by quarter
Q3FY25
ActualEst.
$1.37
$1.37
Q4FY25
ActualEst.
$1.59
$1.58
Q1FY26
ActualEst.
$1.36
$1.37
Q2FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q3FY25
ActualEst.
$1.74B
$1.68B
Q4FY25
ActualEst.
$1.84B
$1.83B
Q1FY26
ActualEst.
$1.8B
$1.81B
Q2FY26
Next Est.
—